In HF patients, levels of circulating total EVs, PMVs and CD31+/CD41- EMVs were considerably higher three hours after intravenous administration of 1000 mg ferric carboxymaltose (FCM) compared to baseline (Figures 1B, C). This evidence concerns the gene ITGA2B and hydrops fetalis.